Freitas Denise, Alvarenga Lênio, Sampaio Jorge, Mannis Mark, Sato Elcio, Sousa Luciene, Vieira Luiz, Yu Maria C, Martins Maria C, Hoffling-Lima Ana, Belfort Rubens
Ophthalmology Department, Federal University of São Paulo, Paulista School of Medicine, São Paulo Hospital, Rua Botucatu 822, 04023-062 São Paulo, Brazil.
Ophthalmology. 2003 Feb;110(2):276-85. doi: 10.1016/S0161-6420(02)01643-3.
To describe an outbreak of mycobacterial keratitis after laser in situ keratomileusis (LASIK), including the microbiologic investigation, clinical findings, treatment response, and outcome.
Retrospective, noncomparative, interventional case series.
Patients (n = 10) who underwent LASIK surgery between August 22 and September 4, 2000, and developed mycobacterial infection.
Patients were prospectively followed in relation to microbiologic investigation, clinical findings, treatment response, and outcome.
Most patients underwent bilateral simultaneous LASIK. Postoperative infection was signaled by the appearance of corneal infiltrates in the third postoperative week. The microbiologic workup was performed on cultures obtained either by direct scraping of the cornea or by lifting the flap. Medical therapy was instituted based on drug susceptibility testing. Surgical interventions such as corneal debridement and flap removal were performed during recurrences or when there was no satisfactory clinical response.
Cultures revealed Mycobacterium subspecies chelonae. Patients were treated with topical clarithromycin (1%), tobramycin (1.4%), and ofloxacin (0.3%). Oral clarithromycin (500 mg twice a day) was prescribed for those patients who did not respond clinically to topical treatment. Four eyes healed on this regimen. Flap removal was necessary in seven eyes.
This report highlights mycobacteria as an etiologic infectious agent after LASIK. Diagnosis can be difficult and is often delayed. The treatment mainstay is prolonged antibiotic therapy. Surgical debridement and flap removal may shorten the disease course.
描述准分子原位角膜磨镶术(LASIK)后发生的分枝杆菌性角膜炎暴发,包括微生物学调查、临床发现、治疗反应及结果。
回顾性、非对照、干预性病例系列研究。
2000年8月22日至9月4日期间接受LASIK手术并发生分枝杆菌感染的患者(n = 10)。
对患者进行前瞻性随访,内容包括微生物学调查、临床发现、治疗反应及结果。
大多数患者接受双侧同时LASIK手术。术后感染表现为术后第3周角膜出现浸润。微生物学检查通过直接刮取角膜或掀起角膜瓣获取的培养物进行。根据药敏试验进行药物治疗。在复发时或临床反应不满意时进行诸如角膜清创和角膜瓣移除等外科干预。
培养物显示为龟分枝杆菌亚种。患者接受局部用克拉霉素(1%)、妥布霉素(1.4%)和氧氟沙星(0.3%)治疗。对局部治疗无临床反应的患者口服克拉霉素(每日2次,每次500 mg)。4只眼按此治疗方案愈合。7只眼需要移除角膜瓣。
本报告强调分枝杆菌是LASIK术后的一种病因性感染病原体。诊断可能困难且常被延误。治疗的主要方法是延长抗生素治疗。外科清创和角膜瓣移除可能会缩短病程。